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ARTICLE
Maintenance of epigenetic landscape requires CIZ1
and is corrupted in differentiated ﬁbroblasts in
long-term culture
Emma R. Stewart1, Robert M.L. Turner1, Katherine Newling 2, Rebeca Ridings-Figueroa1,3, Victoria Scott1,
Peter D. Ashton2, Justin F.X. Ainscough 1 & Dawn Coverley1
The inactive X chromosome (Xi) serves as a model for establishment and maintenance of
repressed chromatin and the function of polycomb repressive complexes (PRC1/2). Here we
show that Xi transiently relocates from the nuclear periphery towards the interior during its
replication, in a process dependent on CIZ1. Compromised relocation of Xi in CIZ1-null
primary mouse embryonic ﬁbroblasts is accompanied by loss of PRC-mediated H2AK119Ub1
and H3K27me3, increased solubility of PRC2 catalytic subunit EZH2, and genome-wide
deregulation of polycomb-regulated genes. Xi position in S phase is also corrupted in cells
adapted to long-term culture (WT or CIZ1-null), and also accompanied by speciﬁc changes in
EZH2 and its targets. The data are consistent with the idea that chromatin relocation during S
phase contributes to maintenance of epigenetic landscape in primary cells, and that elevated
soluble EZH2 is part of an error-prone mechanism by which modifying enzyme meets
template when chromatin relocation is compromised.
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he inactive X chromosome (Xi) is a discrete unit of
facultative heterochromatin that is selected for repression
early in the development of female mammals as a means of
equalizing X-linked gene dosage between the sexes1. Xist long
noncoding RNA (LNCRNA) plays an essential role in the
recruitment of chromatin modifying enzymes to Xi, and the
progressive formation of a stable, heritable repressed state2.
Detailed analysis shows that Xist-dependent polycomb recruit-
ment is initiated by PRC1, and is dependent on the RNA-binding
protein hnRNPK through its interaction with sequences encoded
by Xist repeat B3. Later steps in the polycomb cascade result in
the accumulation of PRC1-mediated H2AK119ub1 and PRC2-
mediated H3K27me3 on Xi chromatin, which is then maintained
through subsequent rounds of cell division4. CIP1/CDKN1A-
interacting zinc ﬁnger protein 1 (CIZ1) is recruited to Xi by Xist
during the earliest stages of X-inactivation dependent on
sequences encoded by Xist repeat E5,6, though lack of overt
embryonic phenotype in CIZ1 null mice suggest that there is no
requirement for CIZ1 during these early stages of X-inactivation5.
However, CIZ1 is required for retention of Xist at Xi in differ-
entiated ﬁbroblasts, and essential for its recruitment during
lymphocyte activation in response to antigen stimulation in adult
mice5, suggesting that it has a post-developmental function at Xi.
CIZ1 has been linked with the neurological disorders cervical
dystonia7 and Alzheimer’s disease8, and with both paediatric9,
and adult common solid tumours including lung, colon, liver and
breast10–13, though no known underpinning molecular function
convincingly links its role in these diverse human pathologies.
Similarly, while a link with lymphocyte activation is established,
the molecular mechanism that underpins its ability to guard
against leukemias and lymphomas in mice is not
understood5,11,14 Moreover, while enrichment at Xi in female
cells is striking (Xi-CIZ1), CIZ1 protein also occupies nucleus-
wide foci in male and female somatic cells (focal-CIZ1)5, and is
elevated in post-replicative male germ cells15 suggesting that it
has additional functions unrelated to the inactive X-chromosome.
In the present study, Xi serves as a well-deﬁned model to probe
the mechanism of action of CIZ1, and shows that CIZ1 is
required to support a change in the preferred location of Xi,
between the nuclear periphery and the nuclear interior, during a
brief window coincident with Xi replication. In CIZ1 null ﬁbro-
blasts, failure to internalize is accompanied by the loss of PRC1/2-
mediated modiﬁcation of Xi chromatin, and relaxation of control
over PRC1/2 target genes across the genome. Crucially, S-phase
internalization of Xi is not observed in ﬁbroblasts in long-term
culture, even if CIZ1 is present, suggesting that the process in
which CIZ1 normally functions is fragile, and corrupted at some
level in cell lines. Moreover, the loss of function in cell lines is
accompanied by up-regulation and increased solubility of PRC2
catalytic subunit EZH2, and in CIZ1 null cells, partial reinstate-
ment of chromatin modiﬁcation at Xi. This raises the possibility
that the mechanism by which modifying enzyme and target
chromatin meet is not the same in primary cells and derived cell
lines. The data support the idea that chromatin relocation during
S phase plays a role in the maintenance of epigenetic state in
primary differentiated cells.
Results
Interaction between CIZ1 and nuclear matrix at Xi in S phase.
Enzymatic removal of chromatin (DNase1) or exposure to ele-
vated non-physiological salt concentrations (500 mM NaCl) have
little effect on either Xi-CIZ1 or focal-CIZ15,16, indicating that
their location in the nucleus is not speciﬁed by association with
chromatin. However, Xi-CIZ1 is sensitive to digestion with RNase
in the majority of cells in a cycling population, indicating that
attachment at Xi is by association with RNA5, most likely Xist6,17.
We focus here on the small fraction of cells (3–7% depending on
cell line and rate of cycling) that resist extraction with RNase so
that CIZ1 remains anchored at Xi (Fig. 1a, b). This indicates
additional or alternative interaction between CIZ1 and non-RNA,
non-chromatin higher-order assemblies, consistent with a bio-
chemically deﬁned nuclear matrix (NM).
The low frequency of retention implies temporal control,
which was supported by analysis in S phase cells. Incorporation of
the nucleotide analogue 5-ethynyl-2ʹ-deoxyuridine (EdU) identi-
ﬁed Xis engaged in DNA replication and showed that Xi
replication occurs in mid S phase in most cells in the ﬁbroblast
populations studied here, though the timing of Xi replication
appears to vary with cell type18,19 (Supplementary Fig. 1). When
combined with immuno-staining for CIZ1, it also showed that
CIZ1 is signiﬁcantly more likely to be resistant to extraction at the
time of Xi replication (Fig. 1c, Supplementary Fig. 1). In fact, over
half of Xi-replicating cells retain CIZ1 at Xi after RNase digestion
(Fig. 1d). This was evident in triplicate independent populations
of primary embryonic ﬁbroblasts (PEFs, deﬁned here as passage 5
or earlier), and remained unchanged in all derived populations
adapted to long-term growth in culture (referred to as mouse
embryonic ﬁbroblasts, MEFs). Thus, during Xi replication, Xi-
CIZ1 undergoes transient interaction with a structure that is
independent of chromatin or RNA.
A shift in Xi location in primary cells but not cell lines. The
location of replicating CIZ1-marked Xis was not the same in PEFs
and MEFs. In primary cells, it was signiﬁcantly more likely to be
seen at locations that did not contact the nuclear periphery
(Fig. 1e). To conﬁrm the preferred position independently of
CIZ1, we monitored the location of EdU-labelled Xis at the time
of Xi replication/EdU incorporation (pulse) compared to its
location 30 min later (chase), and relative to the nucleolar marker
ﬁbrillarin (Supplementary Fig. 1). This showed a greater like-
lihood of overlap with ﬁbrillarin-enriched regions at the time of
the pulse, compared to after a chase period, indicating a change in
preferred location during S phase. Although Xi is located at the
nuclear periphery most of the time, anchored via lamin B
receptor20, these results are consistent with the very earliest
descriptions of the Xi as occupying two distinct locations; the
nuclear periphery or adjacent to nucleoli21.
Importantly, in three populations of primary cells isolated from
independent WT embryos, this change in preferred location
during S phase was readily monitored using a binary classiﬁcation
of peripheral or internal (P or I, Fig. 1f), but in culture-adapted
lines derived from all three parent populations the shift in
location was not evident (Fig. 1f), though replication of Xi took
place in a similarly co-ordinated manner as a condensed EdU-
labelled, CIZ1-marked entity. These data show that Xi replication
is normally coincident with departure from the nuclear periphery,
and suggest that the underlying mechanism for the change in
preferred location is fragile and prone to degradation in culture-
adapted cell lines. Moreover, it suggests that most cell lines likely
do not represent the state of cells in the body with respect to
chromatin dynamics, leading to questions about the functional
relevance of the S-phase location change.
CIZ1 is involved in PRC1/2 target gene regulation. As might be
expected, transcriptome analysis revealed extensive differences
between primary parent cell lines and their culture-adapted
derivatives, with approximately a thousand genes signiﬁcantly
affected (1038 at q < 0.05 (cuffdiff), Fig. 2, Supplementary data 1).
Similar results were achieved using primary and culture-adapted
populations from CIZ1 null mice (904 at q < 0.05 (cuffdiff), Fig. 2,
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Fig. 1 Xi location during S phase. a CIZ1 at Xi in cycling WT primary embryonic ﬁbroblasts (PEFs), with and without extraction of RNA and associated
proteins, detected with anti-CIZ1 antibody 1794 (green). DNA is blue, scale bar 10 microns. b Proportion of cells that retain CIZ1 at Xi (Xi-CIZ1) at the
indicated steps after extraction, for three independent populations of WT PEFs (means ± SEM for 13.1, 13.8, 14.4 at passage 3–4, n > 100 for each step and
each line. Signiﬁcant differences are indicated (t-test). Similar results for culture-adapted derivative line 13.1 (passage > 20), and 3T3 cells is shown below,
±SDEV. c Proportion of cells with RNase-resistant Xi-CIZ1 after pulse-labelling with EdU to classify cells by S-phase stage (Supplementary Fig. 1). Upper
graph shows mean data for WT primary cells 13.1 and 13.8 (passage 3–4), each in duplicate, ±SEM (t-test). Lower graph shows the same analysis for WT
MEFs (13.1, passage > 20), and 3T3 cells, each in duplicate. d Illustration of transient attachment of Xi-CIZ1 (green) to non-chromatin, non-RNA assemblies
(grey circles) during Xi replication. e Location of Xi-CIZ1 at the time of Xi replication (detected by 30min pulse label with EdU) compared to the rest of the
cell cycle. Location is classiﬁed as peripheral or internal (illustrated right). Means ± SEM for three WT PEFs (13.1, 13.8, 14.4 p3–4) are shown (n= 100 for
each), with signiﬁcant changes indicated (t-test). Images show a cell engaged in replication of Xi (EdU, red), co-stained with anti-CIZ1 1794 (green), DNA
is blue, scale bar 10 microns. f Xi location (peripheral or internal) at the time of incorporation of EdU (pulse), or 30min later (chase), analysed by t-test.
Graphs show data ± SEM for three WT primary populations (13.1, 13.8, 14.4 p2–3), and three derived MEF lines (p > 20). EdU-Xi in primary WT cells shifts
preferred location during the chase period, but remains unchanged in most adapted lines, compared by ANOVA. For all analyses *P≤ 0.05, **P≤ 0.01,
***P≤ 0.001. N= independent cell lines, n= total nuclei scored. Individual replicates contributing to each mean are overlaid on bar charts, shaded
according to cell line where necessary
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Supplementary data 1), approximately half of which (405) were
the same genes as those affected in WT cells. For both sets, Gene
Set Enrichment Analysis (GSEA)22 revealed signiﬁcant overlap
with genes regulated by PRC1 and PRC2 (Fig. 3a), as well as those
responsive to Rb and TGFb among others (Supplementary data 2,
tabs 4, 5, 6). PRC subunit expression was itself disrupted upon
culture adaption, evident in both transcript level changes (Sup-
plementary Fig. 2) and in splice variant diversity for some sub-
units (Supplementary Fig. 3, 4).
More informative is the effect of deletion of CIZ1 in primary
cells. We showed previously that, despite enrichment at Xi, the
loss of CIZ1 does not result in widespread reactivation of the
inactive X-chromosome with only 28 X-linked genes signiﬁcantly
upregulated5. Here, we show that the majority of the 65,530
transcription units that align to the rest of mouse genome
assembly GRCm38 are also unaffected (Supplementary data 3,
Fig. 2). However, a sub-set of 266 transcription units (0.4%, q <
0.05 (cuffdiff)) consistently escape normal regulation in PEFs
(Supplementary data 4, Fig. 2), with a similar proportion up- and
down-regulated. Importantly, re-expression of full-length CIZ1
from an inducible integrated vector5 reverses this change back
towards WT levels in 75% of affected genes within 24 h (Fig. 3b, c,
Supplementary data 4) Thus, the expression of a distinct subset of
genes is under the regulation of CIZ1 in primary ﬁbroblasts, and
these are distributed across all chromosomes, including the X.
This is consistent with the interpretation that polycomb-mediated
regulation is the primary pathway governing the expression of a
subset of X-linked genes, and that for the majority inactivity is
maintained by other levels of regulation.
GSEA with these CIZ1-dependent transcription units also
revealed highly signiﬁcant overlap with genes regulated by PRC1
and PRC2 (Fig. 3a, Supplementary data 2, tab 1), though unlike
culture-adapted cells there was little change in PRC subunit
transcript levels (Supplementary Fig. 2), and also no gross change
in the overall immuno-staining pattern for SUZ12, RING1B or
BMI1 in primary cells (Supplementary Fig. 2). Oncogenic
Signature sets that are up-regulated upon the loss of PRC subunits,
or down-regulated upon the gain of PRC subunits, show a strong
correlation (Fig. 3d), while polycomb-linked Curated Gene sets
also support a functional interaction, evidenced by highly
signiﬁcant relationships with those affected by manipulation of
EZH2 (M419623, q < 3.99E−17, where q is one-sided Fisher’s Exact
test with Benjamini–Hochberg false discovery rate (FDR) correc-
tion,) or SUZ12 (M229324, q < 4.53E−22) among others (Fig. 3a,
Supplementary data 2 and Supplementary Tables 1 and 2).
Notably, a similar analysis of the effect of the loss of CIZ1 in
culture-adapted populations returned only 35 CIZ1-dependent
genes (q < 0.05, cuffdiff) and only 12 of these were among those
identiﬁed in primary cells (Fig. 3e–g, Supplementary data 5). This
is because many of those genes whose expression is normally
dependent on CIZ1 are affected by culture adaptation of the WT
state (39% q < 0.05, 56% P < 0.05). Again this argues that adaption
to culture involves corruption of the process in which CIZ1
normally functions.
Deletion of CIZ1 mimics the effect of culture adaptation.
Because CIZ1 is highly enriched at Xi and undergoes speciﬁc
interactions during Xi replication, we tested whether CIZ1 is
required for Xi internalization in triplicate independent primary
CIZ1 null populations. The data show that, unlike WT cells, Xi
fails to change the preferred location within the test window,
remaining primarily associated with the nuclear periphery in both
the pulse and chase (Fig. 4a). It remains possible that a change in
the rate of Xi movement, rather than complete loss of relocation,
could account for the output in this assay. However, the data
clearly show that CIZ1 plays a role in determining Xi location
across the time window (and by implication the residency time at
the nucleolus) thereby linking altered relocation with compro-
mised polycomb function. Consistent with this, both PRC2-
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mediated H3K27me35 and PRC1-mediated H2AK119ub1 are
absent from Xi in primary CIZ1 null cells (Fig. 4b).
These data are consistent with the hypothesis that accurate
receipt of polycomb-mediated chromatin marks is linked with the
delivery of template into sub-nuclear compartments enriched in
spatially restricted modifying enzymes25. In fact, EZH2, SUZ12
and Snf2h (part of the ACF1-ISWI chromatin remodelling
complex involved in heterochromatin replication) have all been
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reported to be enriched at peri-nucleolar locations25–27. In our
analysis, peri-nucleolar enrichment of EZH2 was also detected,
but varied greatly with both cell type and the EZH2 antibody used
(see later).
Promiscuous polycomb activity in cell lines. Strikingly, enriched
H3K27me3 and H2AK119ub1 re-emerges at Xi upon prolonged
culture of CIZ1 null cells (Fig. 4b, c), sometimes describing a
more dispersed Xi territory than in WT cells. This suggests that
the deﬁcit caused by the loss of CIZ1 is overridden during pro-
longed culture, and raises the possibility that similar compensa-
tion might also be taking place in WT cells (in which chromatin
relocation is compromised for reasons unrelated to CIZ1). It
could in fact underpin the relaxed control over polycomb target
b
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incorporation of EdU (pulse) or after (chase), analysed by t-test. Graph shows mean data ± SEM for three WT primary embryonic ﬁbroblasts (green, 13.1,
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gene regulation illustrated in Fig. 3a, d, necessitating a direct
comparison between the different cell states.
CIZ1 deletion or culture adaptation drives a shift in EZH2.
Protein level analysis of the PRC2 catalytic subunit EZH2
resolved two main isoforms in primary cells, though relative
levels vary between WT and CIZ1 null cells (Fig. 5a, b, Supple-
mentary Fig. 3). The upper form (designated EZH2p for primary)
that is dominant in WT cells gives way to a lower form as cells are
adapted to growth in culture, and this is increasingly up-regulated
with passage (Fig. 5a, c). EZH2 transcript assemblies also iden-
tiﬁed differences in prevalence (Supplementary data 6, Supple-
mentary Fig. 3). The most abundant assembly in adapted cells
corresponds to UniProt Q61188 (equivalent to human Q15910-1,
designated EZH2α28), however this is vastly under-represented in
primary cells and replaced by a form with additional 5ʹ sequence.
No canonical translational start codon is evident in the additional
sequence which is currently annotated as 5ʹ UTR. The relation-
ship between EZH2p and the apparent 5ʹ UTR sequence that is
prevalent in the same cells (Supplementary Fig. 3, Supplementary
data 6) is not clear at this time. Electrophoretic mobility suggests
that the lower protein isoform is equivalent to canonical EZH2α,
so in primary ﬁbroblasts EZH2 protein appears to include addi-
tional domains that are not part of the EZH2 that is expressed by
cell lines. A similar analysis of transcript assemblies for the other
subunits of both PRC1 and PRC2 identiﬁed additional changes
linked with either deletion of CIZ1 or culture adaptation (Sup-
plementary Fig. 4).
The relative solubility of EZH2 in primary and culture-adapted
cells point to function-related differences. Both EZH2p and
EZH2α are fully resistant to salt extraction (500 mM) in primary
cells, while half of the EZH2α in culture-adapted cells is
solubilized under the same conditions (Fig. 6a, b), possibly
reﬂecting elevated levels and saturation of binding sites. Similar
results were obtained by quantitative immunoﬂuorescence in
independent WT primary cells and derived cell lines (Fig. 6c,
lower graph). Thus EZH2 shifts isoform, is dramatically elevated
and considerably more soluble in cell lines.
Focusing on the primary cell state, we applied further
extraction steps (Fig. 6a, e) to reveal proteins that are solubilised
along with fragmentation and elution of chromatin, those that are
part of assemblies that are dependent on nuclear RNA, and those
that resist all extraction. This highlights differences in EZH2 that
are driven by the loss of CIZ1. Unlike previous analyses of EZH2
in embryonic stem cells29, the prevalent form in WT cells
(EZH2p) does not depend on either RNA or DNA for retention
in the nucleus. However, the prevalent form in CIZ1 null cells
(EZH2α) is largely released by the removal of RNA (Fig. 6e, f).
Consistent results were achieved by immuno-microscopy in two
independent primary lines each for WT and CIZ1 null genotypes
conﬁrming distinct differences in extraction proﬁle (Fig. 6c upper
graph, d), and is in line with analyses of recombinant PRC2
which report promiscuous RNA-binding capability30. Thus,
EZH2α lacks the ability to become anchored within the nucleus
to non-chromatin, non-RNA protein assemblies (Fig. 6g).
Most of the analysis in this study was carried out using EZH2
antibody CSTD2C9 which recognises both EZH2p and EZH2α in
western blots (Fig. 5a), and gives relatively evenly distributed
nuclear foci by immunoﬂuorescence in either primary or adapted
cells before extraction (Fig. 6d, Supplementary Fig. 3). In contrast,
EZH2 antibody STJ112944 has higher afﬁnity for EZH2p than
EZH2a in western blots (Supplementary Fig. 3) and reveals a
distinctly different pattern in primary cells but not adapted cells
(Supplementary Fig. 3). Comparison to the nucleolar marker
ﬁbrillarin identiﬁed this as peri-nucleolar enrichment (Fig. 7a),
and is consistent with the idea that EZH2p represents a
functionally distinct and spatially restricted form of EZH2 in
primary cells.
Both EZH2 antibodies were also applied in proximity ligation
studies with CIZ1, to reveal locations in the nucleus where the
two proteins are in close proximity (Fig. 7b). We did not see a
large signal comparable to the enrichment of CIZ1 at Xi with
either antibody, in any cell type, or at any stage in the cell cycle,
which would be consistent with a stochastic interaction between
EZH2 and Xi chromatin. However in WT cells, but not CIZ1 null
cells, both EZH2 antibodies return a signal at discrete locations in
the nucleus, indicating proximity to within 40 nm of each other at
those sites. In line with the western blot data in Fig. 5a, for
EZH2p (antibody STJ112944), the number of colocalizing sites is
reduced in adapted WT cells compared to primary WT cells.
Moreover, consistent with the observation that CIZ1-Xi is
compromised in its ability to internalize in adapted cells, fewer
of these colocalizing sites are located internally in culture adapted
cells compared to primary cells.
Discussion
The data identify two drivers for the shift from EZH2p to EZH2α;
the loss of CIZ1 in primary cells and culture-adaptation in both
genotypes (Fig. 6g). Both drivers also result in the loss of observed
S-phase location change and relaxed PRC-mediated control of
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gene expression (summary model, Fig. 8). We propose here that
these parameters are linked, and suggest that soluble EZH2 that is
released from spatial constraint may be a compensatory response
to the loss of chromatin relocation capacity, enabling reinstate-
ment of essential regulatory events, including the observed rein-
statement of H3K27me3 at Xi in CIZ1 null cells. By analogy with
our previous analysis of the solubility transition of cyclin E in
human, mouse and Xenopus differentiation models31, we further
suggest that unconstrained enzyme may represent reversion,
during culture, to a less differentiated state.
Notably, in addition to a shift in solubility, culture-adapted
cells also experience the elevation of EZH2 protein. Promiscuous
activity and gain-of-function mutations in EZH2 are documented
in a wide range of human cancers prompting interest in its
potential as a therapeutic target32. The data presented here
illustrate distinctions between EZH2 in normal cells in the body
compared to EZH2 in transformed cells in culture, in terms of
isoform, protein levels and solubility, which could inform design
of selective interventions and should be considered in relation to
the variable therapeutic response to inhibitors of EZH232.
Moreover, changes in polycomb function as a consequence of
CIZ1 disruption, highlights a pathway by which the varied CIZ1-
related diseases may arise. The switch in isoform expression,
emergence of unconstrained wild enzyme and relaxed control
over target selection that we show here, are consistent with the
idea that compromised chromatin relocation may be a driver of
epigenetic drift.
Moreover, the data strongly reinforce the message that culture-
adapted ﬁbroblast cell models do not fully represent the func-
tional state of cells in the body, thereby restricting the application
of somatic cell genetic modiﬁcation strategies that include selec-
tion to derive clonal lines.
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Long-range directional movement of chromatin has been stu-
died in detail using tagged loci and live imaging approaches in
CHO cells33 or transformed human cell lines34. The latter iden-
tiﬁed distinct nuclear substructures (nucleolus and nuclear per-
iphery) that locally constrained the movement of a subset of loci
but did not report evidence for transient relocation between those
sites, while the former measured inducible unidirectional migra-
tion of an engineered locus from the periphery to the nuclear
interior. This study, and others that focus on chromosome ter-
ritory relocation during DNA repair35 or entry to quiescence36 in
early passage human ﬁbroblasts, have begun to implicate the
chromatin-bound motor protein nuclear myosin 1 (NM1)37,
though little mechanistic detail has yet been uncovered.
The data presented here implicate CIZ1 in a mechanism
underpinning Xi relocation in S phase, however a number of
observations argue that this function extends beyond Xi to other
loci. These are the presence of focal-CIZ1 in both male and
female nuclei5, similar expression proﬁles in both male and
female differentiating ES cells6, and the genome-wide effect of
deletion of CIZ1 on polycomb-regulated gene expression. It
should be noted that the present analysis does not directly address
whether polycomb-regulated genes elsewhere in the genome visit
the nucleolus. However, the behaviour of Xi, which can be readily
monitored via locally high concentrations of CIZ1, appears to be
a valuable and tractable native context in which to unpick the
requirements of long-range chromatin relocation events.
Crucially, capacity to relocate Xi was compromised in all of
the cell lines we studied, precluding full mechanistic analysis of
the role of CIZ1 in cell lines. However, because cell-cycle-
dependent recruitment of Xi-CIZ1 to RNA-independent
assemblies is retained in these cells, we can infer that any role
that this interaction plays in Xi relocation is not sufﬁcient on its
own, and that the relocation process is likely compromised at
another level. To understand the mechanism by which reloca-
tion is normally achieved we now need to (i) deﬁne the tran-
sient S-phase speciﬁc interaction between CIZ1 and the NM
(chromatin and RNA-independent assemblies), and (ii) in cells
that are competent to support an S phase shift in location of Xi,
ask what role this plays in the maintenance of epigenetic
landscape in daughter cells. An important caveat is that we
cannot yet be certain that the impact on Xi location in CIZ1
null cells is direct or indirect, but the above approaches will
help to establish the relationship.
A pivotal role for LNCRNAs in long-range movement of
chromatin is suggested by disruption of Xist25 and Firre38 (which
also results in the loss of H3K27me3 from Xi), and by studies
unrelated to Xi, which implicate Kcnq1ot1 in perinucleolar tar-
geting of an episomal vector during mid-S phase39,40. Again this
was shown to contribute to silencing of linked genes by EZH241.
Thus, locus-speciﬁc relocation as a means of maintaining epige-
netic state is an emerging function of LNCRNAs and is supported
by independent studies. CIZ1 interacts with Xist via its repeat E
and is dependent on repeat E for accumulation at Xi5,6, appar-
ently through most of the cell cycle. The S-phase switch in CIZ1
interaction proﬁle leads us to consider whether a primary func-
tion of CIZ1 may be to transiently link Xist-coated Xi chromatin
to machinery that supports Xi transit in S phase, thereby coupling
replication to relocation. Such an S-phase-speciﬁc function for
CIZ1 is consistent with previous analyses which have identiﬁed
direct and sequential interactions with cyclin E and cyclin A42,
and regulatory phosphorylation sites which impact on CIZ1s
function in DNA replication43, though at present are difﬁcult to
reconcile with data which suggest a link with pre-IC conversion43.
While the role of CIZ1 in determining Xi location in primary
cells is beginning to emerge, the drivers that lead to the loss of S-
phase location change in WT cells in long-term culture and the
molecules affected, remain opaque. It could reﬂect changes in
Xist25 or Firre38, or other chromatin-associated RNAs44, or a
corrupted NM, or other factor such as NM1. However, all we can
safely conclude at this stage is that corruption of the process in
which CIZ1 normally functions is a recurrent feature of culture-
adapted cells.
In summary, our data are consistent with the model that the
selection of EZH2 target chromatin may be achieved by divergent
pathways with differing ﬁdelity. (i) A CIZ1-dependent,
replication-linked pathway operating in normal WT somatic cells
that supports timely and controlled meeting of spatially restricted
enzyme and template via transient relocation of chromatin, and
(ii) a CIZ1-independent pathway that is not dependent on
chromatin relocation. Based on proﬁling the expression, location
and binding characteristics of EZH2, we further hypothesize that
release and up-regulation of EZH2 methyltransferase could
Primary WT Primary CIZ1 null Culture-adapted
S phase
Interphase
Xi CIZ1
Replicating Xi EZH2p EZH2α Nucleolus   
RNase and DNase 
-resistant assembly
Fig. 8 Summary model. Summary model depicting two alternative pathways by which chromatin and modifying enzymes could meet. Left, anchored and
spatially restricted EZH2p (orange) in WT primary cells, and CIZ1-dependent relocation of Xi during replication of Xi. Centre, compromised relocation of Xi
in CIZ1 null PEFs and loss of marks from Xi. Right, elevated wild EZH2α (blue) in culture-adapted cells is depicted diffusing to sites of action. We propose
that this compensates for the loss of Xi relocation capability but could lower the stringency with which epigenetic state is maintained in cycling somatic
cells
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compensate for the loss of relocation capability, enabling chro-
matin maintenance (at the expense of ﬁdelity) in rapidly cycling
cells. While the evidence for this last point is currently circum-
stantial, based on the data presented here, we are able to safely
conclude that CIZ1 is part of a mechanism that contributes to
accurate maintenance of epigenetic landscape in primary cells,
and suggest that this pathway more closely reﬂects the status of
normal differentiated cells in the body.
Methods
Cell isolation, culture and derivation of lines. CIZ1 null mice were generated
from C57BL/6 ES clone IST13830B6 (TIGM) harbouring a neomycin resistance
gene trap inserted downstream of exon 1. The absence of Ciz1/CIZ1 in homo-
zygous progeny was conﬁrmed by qPCR, immunoﬂuorescence and immunoblot5.
Mouse PEFs were derived from individual embryos at days 13–14 of gestation. All
primary and culture adapted MEFs were cultured in DMEM GlutaMAX (Gibco)
supplemented with 10% FBS (PAA) and 1% Pen/Strep/Glutamine (Gibco). During
rapid proliferation phase, cells were grown to 90% conﬂuence then passaged 1:3
every 2–3 days. Populations of cells cultured up to passage (p) 5 were considered
early passage (speciﬁed in text), and designated here as primary cells. Experiments
were not performed after passage 5, unless to generate culture adapted lines
(Supplementary Table 3). To achieve this, beyond passage 5, cells were supple-
mented with fresh media every 3 days and passaged at 90% conﬂuence (typically
once per week as proliferation rate slowed) without dilution (passage ratio 1:1). By
passage 10–12 individual colonies of intermediate state cells emerged, that were
dissociated and replated as a whole (1:1) until rapidly proliferating culture adapted
populations emerged by passage 20 and designated as culture adapted lines. These
were routinely grown to 90% conﬂuence then passaged as for primary cells. For
inducible cells harbouring transactivator and responder transgenes, the addition of
doxycycline to media (5–10 μg/ml) was used to induce GFP-CIZ1 within 6 h.
Female 3T3 cell line D00145 (a kind gift from Stephen Downes) were grown in the
same media.
Ethics. All work with animal models is compliant with UK ethical regulations.
Breeding and genetic modiﬁcation of mice were carried out under UK Home Ofﬁce
license and with the approval of the Animal Welfare and Ethical Review Body at
the University of Leeds. Analysis on cells and tissues derived from these mice was
carried out with the approval of the Animal Welfare and Ethical Review Body at
the University of York.
Sub-nuclear fractionation. All buffers were made in RNase-free water. All
reagents were from Sigma unless otherwise stated. All samples are named by the
last treatment in the series that they received. Extraction for analysis by western
blot46 is detailed below, and extraction for analysis by immunoﬂuorescence
microscopy47 was performed on cells grown on coverslips using the same buffers.
Brieﬂy, plates of adherent cells were washed twice in ice-cold PBS then twice in ice-
cold cytoskeletal buffer (CSK: 10 mM PIPES/KOH pH 6.8, 100 mM NaCl, 300 mM
Sucrose, 1 mM EGTA, 1 mM MgCl2, 1 mM DTT, 1 cOmplete™ Protease Inhibitor
Cocktail per 50 ml) and drained at a shallow angle on ice for 2 min. Cells were
scrape harvested and supplemented with 2 mM PMSF before addition of Triton-X-
100 to 0.1% and, to samples not subsequently receiving RNase, vanadyl ribonu-
cleoside complex (VRC) to 2.5 mM (NEB). Samples were mixed by pipetting, and
after 1 min on ice, centrifuged at 1000 × g. The soluble fraction from this stage was
designated detergent (det.) supernatant (S, sample i Fig. 6b). The pellet fraction was
either denatured for analysis by SDS-PAGE (det. P, ii) or resuspended in 0.1%
Triton-X-100 and 0.5 M NaCl in CSK and incubated on ice for 1 min before second
centrifugation at 1000 × g (salt S, iii, and P, iv). Pellets to be further extracted were
washed with digestion buffer (40 mM Tris/HCl, 10 mM NaCl, 6 mM MgCl2, 1 mM
CaCl2, pH 7.9, supplemented 1/500 with RNaseOUT for RNase-free samples),
before resuspension in fresh digestion buffer. Samples were then incubated at 30 °C
for 1 h with gentle agitation in the presence of DNase1 (Roche 04716728001) at
0.3 U/μl, RNase (Roche 11119915001) 0.5 U/μl, or both DNaseI and RNase, or no
enzyme (mock). Before ﬁnal centrifugation, reactions were supplemented to 0.5 M
NaCl for 5 min, then separated to yield pellets (P, vi and viii) and supernatants (S, v
and vii). Pellets were resuspended in 1× denaturing buffer (2% SDS, 15% glycerol,
1.7% betamercaptoethanol, 75 mM Tris pH 6.8 with bromophenol blue), and
supernatants supplemented with 4× denaturing buffer and heated to 95 °C with
repeated vortexing to shear remaining nucleic acid. For extraction for analysis by
immunoﬂuorescence, coverslips were incubated with CSK supplemented with 0.1%
Triton-X-100 and 2.5 mM VRC (CSK-D) for 1 min. Following CSK-D removal
coverslips were either ﬁxed with 4% paraformaldehyde (detergent sample) or
incubated with CSK-D with 0.5 M NaCl (CSK-DS) for 1 min. For coverslips to be
treated with RNase, VRC was left out from this step onwards. Coverslips were
washed twice for 1 min with digestion buffer (supplemented with 2.5 mM VRC for
non-RNase samples) before incubation for 1 h at 37 °C in digestion buffer with
2.5 mM VRC (High Salt sample), digestion buffer supplemented with 2.5 mM VRC
and DNase1 at 0.45 U/μl (DNase sample) or digestion buffer supplemented with
RNase at 0.75 U/μl (RNase sample). Coverslips were incubated for 1 min with CSK-
DS (supplemented with 2.5 mM VRC for non-RNase samples) before ﬁxation with
4% paraformaldehyde.
Antibodies and detection protocols. For western blots, adherent cells were either
extracted as above or, after washing in ice-cold PBS, scrape harvested into dena-
turing buffer with fresh 2 mM PMSF, to generate whole cell lysates. Samples were
heated to 95 °C and separated through 4–15% gradient gels (Bio-Rad) then
transferred onto nitrocellulose membranes using the iBlot system (Invitrogen).
Blots were blocked in either 5% low-fat milk in PBS with 0.1% Tween-20, or 5%
BSA in TBS with 0.05% Tween-20, depending on antibody, then incubated with
primary antibodies overnight at 4 °C with gentle agitation. Blots were washed and
probed with HRP-conjugated anti-species secondary antibodies for 1 h at room
temperature (Jackson Immunochemicals 115-035-174 and 211-032-171), and
imaged using EZ-ECL (Biological Industries) with a Syngene PXi chemilumines-
cence imaging system. Band intensities were quantiﬁed using GeneSys
4.03.05.0 software. Uncropped blots for the images used in main ﬁgures are shown
in Supplementary Fig. 5. For immunoﬂuorescence microscopy, cells grown on glass
coverslips were washed with PBS before ﬁxation in 4% paraformaldehyde, or where
indicated bathed in CSK with 0.1% Triton-X-100 for 1 min prior to ﬁxation. After
ﬁxation cells were rinsed twice with PBS then incubated for 15 min in BSA
Antibody buffer (0.02% SDS, 0.1% TX100, 10 mg/ml nuclease-free BSA in PBS),
followed by 2 h at 37 °C with primary antibody (in BSA antibody buffer). After
three washes in the same buffer, anti-species secondary antibodies (Alexa Fluor 488
or 568) were applied for 1 h, followed by three further washes, and mounting in
VectorShield with DAPI (Vector Labs). All antibodies including dilutions are listed
in Supplementary Table 4.
Proximity ligation assay. Primary WT, primary CIZ1 null and culture adapted
WT murine embryonic ﬁbroblast cells were grown on glass coverslips and washed
with 0.1% Triton-X-100 containing PBS prior to ﬁxation with 4% paraformalde-
hyde for 15 min. Coverslips were blocked and incubated with primary antibodies as
usual before washing with Duolink® In Situ Wash Buffer A and the proximity
ligation assay detailed in Duolink® PLA ﬂuorescence protocol (Sigma), using
species-speciﬁc secondary antibody probes and green detection reagents. In brief,
following standard primary antibody incubation as detailed in antibodies and
detection protocols, coverslips were washed twice for 5 min with Wash Buffer A
and incubated with species-speciﬁc PLUS and MINUS PLA probes in the provided
antibody diluent for 1 h at 37 °C. Coverslips were washed twice for 5 min with
Wash Buffer A before incubation for 30 min at 37 °C with 1× Ligation Buffer
supplemented with DNA Ligase. Coverslips were washed twice for 5 min with
Wash Buffer A followed by incubation for 100 min at 37 °C in Ampliﬁcation buffer
supplemented with DNA polymerase. Coverslips were washed twice for 10 min
with Wash Buffer B before a ﬁnal 1 min wash in 0.01× Wash Buffer B and
mounting in Vector Shield with DAPI (Vector Labs).
Imaging. Fluorescence images were captured using a Zeiss Axiovert 200M ﬁtted
with a 63×/1.40 Plan-Apochromat objective and Zeiss ﬁlter sets 2, 10, 15 (G365
FT395 LP420, BP450-490 FT510 BP515-565, BP546/12 FT580 LP590), using
Axiocam 506 mono and Axiovision image acquisition software (SE64 release 4.9.1).
Where changes in ﬂuorescence intensity are quantiﬁed across an extraction series,
coverslips were imaged as a set with all images for each ﬁlter set captured with the
same exposure time. Images were saved at 1499 by 1205 pixels in tagged image ﬁle
format for downstream analysis. For EZH2 at least 50 individual nuclei from
unmodiﬁed images were quantiﬁed for each cell population and each extraction
condition, using Fiji48. Where indicated, EZH2 levels across an extraction series
were normalized to the detergent-treated sample (given an arbitrary value of 100)
to enable comparison between cell lines. For presentation, images were enhanced
using Adobe Photoshop CS4 or Afﬁnity Photo 1.5.2, maintaining identical
manipulations across extraction series so that image intensities reﬂect actual
relationships (unless speciﬁcally stated otherwise). All quantiﬁcation of image
intensity was carried out prior to manipulation. For the presentation of images
illustrating positional, rather than intensity information, images were not neces-
sarily modiﬁed identically.
S phase labelling. 5-Ethynyl-2ʹ-deoxyuridine (EdU, 10 μM) was added to adherent
cells on coverslips at ~70% conﬂuence for a 30 min pulse period under standard
growth conditions. For pulse/chase experiments, coverslips were transferred to
warm PBS then into fresh media (without EdU) for 30–60 min. To visualize newly
synthesized DNA, coverslips were washed brieﬂy in CSK with 0.1% Triton-X-100,
or subjected to extraction up to the RNase treatment step before ﬁxation with 4%
paraformaldehyde for 15 min. Coverslips were then washed in PBS and EdU
detected using the Click-iT® EdU Alexa Fluor® 594 kit (ThermoFisher), as
recommended. Brieﬂy, coverslips were blocked with 3% BSA before incubation in a
light-proof humidiﬁed chamber with Click-iT® reaction cocktail for 60 min. For
dual staining (e.g. CIZ1 or ﬁbrillarin), coverslips were ﬁrst incubated with primary
antibody as described under antibodies and detection protocols before blocking
with 3% BSA. Anti-species secondary antibody diluted in Click-iT® reaction buffer
was included in the EdU detection step. Coverslips were then washed and mounted
using VectorShield with DAPI (Vector Labs).
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Positional analysis of Xi. Typically, 30–50% of cells in a rapidly cycling population
incorporate EdU during a 30min pulse labelling period. Of these, 6–16% have one or
two compact discrete patches of incorporated EdU against an early or mid S-phase
replication pattern, veriﬁed as Xi by co-staining with CIZ1. The location of EdU-
labelled Xi was scored in two ways. (i) By proximity to the nucleolar marker ﬁbrillarin
and the nuclear envelope, generating four categories illustrated in Supplementary
Fig. 1. Xis were classiﬁed as peripheral if any part of its territory or individual foci that
are part of a cluster were not resolvable from the nuclear perimeter, conﬁrmed by
comparison with DAPI. Xis were scored as nucleolar if any part of the territory or foci
were unresolvable from ﬁbrillarin stain. Xi which meets both of these criteria were
classiﬁed as peripheral/nucleolar, or neither if both of the criteria were not met. (ii) A
binary classiﬁcation, based on the criteria above (Supplementary Fig. 1), was used to
gather time-resolved data points. Xis were scored as internal if all of the territory,
including all foci, was resolvable from the nuclear periphery, and peripheral if these
criteria were not met. For nuclei with two EdU-labelled Xis both were classiﬁed
individually. Nuclei with more than two EdU-labelled Xis were excluded from the
analysis. At least 100 labelled nuclei were imaged per coverslip, with at least 3 replicate
coverslips, and three biological replicate cell populations (from independent embryos)
of each genotype. Results in Fig. 4a show compromised of Xi relocation in CIZ1 null
cells, and results in Fig. 1f show a gradual diminishing of Xi relocation in WT adapted
lines (evidenced by lack of change in the proportion of peripheral Xis between pulse
and chase). However, in some adapted cells we were not able to score location because
of the absence of a clearly deﬁned CIZ1 mark and also apparent incoherent replication
of Xi. In these cells, replicating Xi was no longer detectable as a patch of dense EdU
against a mid-S phase nucleus, and neither was it identiﬁable against early or late
replicating nuclei because CIZ1 was dispersed or absent. This most likely reﬂects
instability of Xi in transforming cells, illustrated previously in the context of breast
cancer49. These cell populations were typically late passage (p20 or more) and were
excluded from the analysis.
Statistical analysis. Experiments were designed to use the minimum number of
animals while achieving statistically valid data and include two types of analysis.
For multivariate data (lists of genes or proteins that are changed in one genotype
compared to another) three biological replicates (independent PEF lines) enables
calculation of average log 2 fold change and T-test P-values, as well as FDR-
adjusted P-value for each data point (gene), and is the minimum required for
differential expression analysis using Cuffdiff. Randomization is not appropriate,
and PEF lines are matched as closely as possible. For single parameter endpoints
such as analysis the requirements of Xi relocation, the variable is sampling time,
and the output one of two positions, with typical effect size of 3 and analysis using
two sample t-test in Excel. Unless indicated, data is represented as means with
SEM. Comparison of the differing Xi relocation behaviour of WT and CIZ1 null
cells was evaluated in R using a two-way ANOVA. *P < 0.05, **P < 0.01, ***P <
0.001. Avoidance of bias is achieved by independent, blinded analysis of archived
images, for tests with optimised parameters. For example, if 1 mg/ml etoposide in
the 30 min EdU chase period inﬂuences return of Xi to the nuclear periphery after
replication, data (images) from replicate experiments will be archived, coded and
blind scored by independent workers.
Transcriptome analysis. Primary (before passage 5) and culture-adapted derivative
cell lines of murine embryonic ﬁbroblasts 13.1, 13.8 and 14.4 (female WT), and 13.15,
13.17, 14.2 and 14.19 (female CIZ1 null) were grown to 80% conﬂuence. RNA was
extracted with TRIzol (Ambion 15596-026) following manufacturer’s instructions.
Brieﬂy, adherent cells grown to 80% conﬂuence were washed twice with PBS, drained
on a shallow angle for 2min and excess PBS removed. 1ml of TRIzol was added per
28 cm2 and incubated for 3–5min at room temperature with periodic agitation.
Lysates were collected in clean Eppendorf tubes. Chloroform was added to a ratio of
1:5 and lysates were shaken vigorously for 15 s before incubation at room temperature
for 3min before centrifugation at 12,000 × g for 15min. The aqueous phase was
transferred into a clean Eppendorf and mixed with equal volume of isopropanol
through gentle inversion and incubated at room temperature for 10min, followed by a
10min centrifugation at 12,000×g. Supernatant was removed, and the RNA pellet
washed with an equal volume of 75% ethanol to the volume of TRIzol used to extract
the RNA. Sample was centrifuged for 5min at 12,000 × g and the supernatant
removed. RNA pellet was resuspended in nuclease-free water. Isolated RNA was then
treated with DNase (Roche 04716728001), before quality analysis by agarose gel,
NanoDrop spectrophotometer and Agilent 2100 Bioanalyzer. Libraries were prepared
with NEBNext® Ultra™ RNA Library Prep Kit for Illumina®, and enriched for mRNA
using NEBNext Poly(A) mRNA Magnetic Isolation Module, which is optimized for
the production of libraries with 250–400 bp inserts. Enriched mRNA was fragmented
by heating to 95 °C for 12min, cDNA synthesised from random primers, followed by
end repair, dA-tailing, adaptor ligation and PCR enrichment. Libraries were sequenced
at the Leeds Institute for Molecular Medicine (LIMM) using Illumina 3000 system,
using paired-end sequencing to generate ~50 million reads per sample. Sequence reads
were trimmed to remove any adapter sequences using Cutadapt version 1.8.350 then
aligned to version GRCm38 of the mouse genome using HISAT251. Transcriptomes
were assembled and gene expression quantiﬁed using the Tuxedo pipeline (version
2.2.1)52, from which predicted splice variant assemblies were extracted, including those
that map to the EZH2 locus 6:47530040–47595351 (Supplementary Fig. 3,
Supplementary data 6) and other PRC subunits (Supplementary Fig. 4). Average
expression of each splice variant was calculated from the 3 independent lines for WT
and CIZ1 null primary and culture adapted cells. Variants arising from sequencing of
the opposite strand were removed. Total expression of the gene was calculated for each
cell type along with the percentage of each splice variant. Splice variants contributing
less than 5% of the total in all cell types were removed from the analysis to simplify
visual representation. Cufﬂinks was used to assemble transcriptomes for each sample
using the GTF annotation ﬁle for the GRCm38 mouse genome (C57BL/6), followed by
Cuffmerge to merge individual sample transcriptomes. Quantiﬁcation, normalisation
and differential expression were carried out using Cuffquant, Cuffnorm and Cuffdiff,
respectively. GSEA22,53 was performed in Python 3.6 using one-sided Fisher’s Exact
tests as part of the SciPy library (v.0.19.0). FDR was controlled using the
Benjamini–Hochberg method in the StatsModels library (v.0.8.0), to generate q values.
As this correction is based on P-values and different comparisons have different
numbers of P-signiﬁcant expression changes, the threshold at which q-signiﬁcance is
reached will vary between comparisons, as reﬂected in the volcano plots in Fig. 2.
Volcano plots were generated in Excel. Heat maps were generated using Spyder
(v.3.1.4), accessed via Anaconda Distribution (v.1.6.2), using the pandas, seaborn and
matplotlib modules. Transcription units which did not have a numerical value for
log2(fold change) due to mean expression of 0 in one condition were manually
removed before generating the plots. Individual fragment counts per kilobase per
million (FPKM) were extracted for replicate cell lines to calculate means and SEM.
Reporting summary. Further information on experimental design is available in
the Nature Research Reporting Summary linked to this article.
Code availability. The custom code used to perform Gene Set Enrichment Ana-
lysis is available from authors upon request. All versions of software used are
described in transcriptome analysis methods.
Data availability
Transcriptome data is available at GEO repository under accession code
GSE122235. All other relevant data supporting the key ﬁndings of this study are
available within the article and its Supplementary Information ﬁles or from the
corresponding author upon reasonable request.
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